Greykasell Wealth Strategies, Inc.
Source: SEC Form 13F · as of Mar 2026Greykasell Wealth Strategies, Inc. holds 25 biotech & pharma companies tracked by BioSniper, totaling $5.4M in value as of Mar 2026 (SEC Form 13F).
Companies held
25
Total value held
$5.4M
| Company | Shares | Value |
|---|---|---|
| ABBVAbbVie Inc. | 5,589 | $1.2M |
| AMGNAMGEN INC | 3,142 | $1.1M |
| JNJJOHNSON & JOHNSON | 3,161 | $773K |
| REGNREGENERON PHARMACEUTICALS, INC. | 478 | $369K |
| LLYELI LILLY & Co | 381 | $350K |
| NVSNovartis AG | 2,013 | $307K |
| GMOptec International, Inc. | 3,228 | $240K |
| GILDGILEAD SCIENCES, INC. | 1,500 | $209K |
| PMPhilip Morris International Inc | 844 | $140K |
| AZNASTRAZENECA PLC | 690 | $136K |
| BMYBRISTOL MYERS SQUIBB CO | 1,848 | $112K |
| NVONovo Nordisk A/S | 2,269 | $83K |
| BIIBBIOGEN INC. | 385 | $71K |
| MCKMcKesson Corporation | 68 | $59K |
| IDXXIDEXX LABORATORIES INC /DE | 76 | $43K |
| CAHCardinal Health Inc. | 186 | $39K |
| PFEPFIZER INC | 1,310 | $37K |
| MRKMerck & Co., Inc. | 251 | $30K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 47 | $21K |
| ABTABBOTT LABORATORIES | 177 | $18K |
| GEHCGE HealthCare Technologies Inc. | 123 | $9K |
| GMEDGlobus Medical Inc. | 79 | $7K |
| CRSPCRISPR Therapeutics AG | 68 | $3K |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 4 | $1K |
| ZTSZoetis Inc. | 3 | $296 |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.